What does DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE do?

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is a general practice in Merchtem. Private Limited, started on 22 December 2009, 1 establishment.

What is the address of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE?

The registered office of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is located at Spiegellaan 5, 1785 Merchtem.

Is DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE still active?

Yes. According to the CBE (29 September 2026) DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 22 December 2009.

Is DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE registered on Peppol?

Yes, DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is registered on the Peppol network with ID 0208:0821670073.

What is the enterprise number of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE?

The enterprise number of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is BE0821670073.

Who are the directors of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE?

According to the 2026 annual accounts, the directors of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE are: Liliane Lombaert.

Is DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2009; 6 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE make in 2026?

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE posted a profit after taxes of € 150,074 in financial year 2026.

What is the revenue of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE?

As a small company, DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 14,020.

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE (Private Limited)

Q: When was DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE founded?

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE was founded on 22 December 2009.

Dossier DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE, printed on 29 September 2026 from databakkes.be/en/0821670073/dokter-liliane-lombaert-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE from Merchtem, company number BE0821670073, closed financial year 2026 with a result of € 150,074 after tax. For that financial year DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE recorded a gross margin of € 14,020 and equity of € 701,672. Compared with financial year 2025, the result moved from € 104,359 to € 150,074. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Growing

€ 701,672

▲ 27% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 150,074

▲ 44% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 55

▼ € 67,622 vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 689,272.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 130,564 Gross margin 2023: € 130,564 First fiscal year in the series	€ 172,155 Gross margin 2024: € 172,155 ▲ 32% vs 2023 (€ 130,564) Favourable step	€ 162,196 Gross margin 2025: € 162,196 ▼ 6% vs 2024 (€ 172,155) Unfavourable step	€ 14,020 Gross margin 2026: € 14,020 ▼ 91% vs 2025 (€ 162,196) Unfavourable step	▼ 91%
Profit after taxes	€ 78,329 Profit after taxes 2023: € 78,329 First fiscal year in the series	€ 107,242 Profit after taxes 2024: € 107,242 ▲ 37% vs 2023 (€ 78,329) Favourable step	€ 104,359 Profit after taxes 2025: € 104,359 ▼ 3% vs 2024 (€ 107,242) Unfavourable step	€ 150,074 Profit after taxes 2026: € 150,074 ▲ 44% vs 2025 (€ 104,359) Favourable step	▲ 44%
Equity	€ 339,997 Equity 2023: € 339,997 First fiscal year in the series	€ 447,239 Equity 2024: € 447,239 ▲ 32% vs 2023 (€ 339,997) Favourable step	€ 551,598 Equity 2025: € 551,598 ▲ 23% vs 2024 (€ 447,239) Favourable step	€ 701,672 Equity 2026: € 701,672 ▲ 27% vs 2025 (€ 551,598) Favourable step	▲ 27%
Total debts	€ 53,064 Total debts 2023: € 53,064 First fiscal year in the series	€ 45,259 Total debts 2024: € 45,259 ▼ 15% vs 2023 (€ 53,064) Favourable step	€ 48,141 Total debts 2025: € 48,141 ▲ 6% vs 2024 (€ 45,259) Unfavourable step	€ 57 Total debts 2026: € 57 ▼ € 48,083 vs 2025 (€ 48,141) Favourable step	▼ € 48,083
Cash	€ 47,462 Cash 2023: € 47,462 First fiscal year in the series	€ 78,410 Cash 2024: € 78,410 ▲ 65% vs 2023 (€ 47,462) Favourable step	€ 67,676 Cash 2025: € 67,676 ▼ 14% vs 2024 (€ 78,410) Unfavourable step	€ 55 Cash 2026: € 55 ▼ € 67,622 vs 2025 (€ 67,676) Unfavourable step	▼ € 67,622
Land & buildings	€ 3,332 Land & buildings 2023: € 3,332 First fiscal year in the series	€ 2,922 Land & buildings 2024: € 2,922 ▼ 12% vs 2023 (€ 3,332) Unchanged	€ 2,511 Land & buildings 2025: € 2,511 ▼ 14% vs 2024 (€ 2,922) Unchanged	-
Retained profit	€ 327,597 Retained profit 2023: € 327,597 First fiscal year in the series	€ 434,839 Retained profit 2024: € 434,839 ▲ 33% vs 2023 (€ 327,597) Favourable step	€ 539,198 Retained profit 2025: € 539,198 ▲ 24% vs 2024 (€ 434,839) Favourable step	€ 689,272 Retained profit 2026: € 689,272 ▲ 28% vs 2025 (€ 539,198) Favourable step	▲ 28%
Bank debt	€ 0 Bank debt 2023: € 0 First fiscal year in the series	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 2,026 Bank debt 2025: € 2,026 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2026: € 0 ▼ 100% vs 2025 (€ 2,026) Favourable step	▼ 100%
Balance sheet total	€ 393,061 Balance sheet total 2023: € 393,061 First fiscal year in the series	€ 492,498 Balance sheet total 2024: € 492,498 ▲ 25% vs 2023 (€ 393,061) Unchanged	€ 599,738 Balance sheet total 2025: € 599,738 ▲ 22% vs 2024 (€ 492,498) Unchanged	€ 701,729 Balance sheet total 2026: € 701,729 ▲ 17% vs 2025 (€ 599,738) Unchanged	▲ 17%

Key figures of DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 24 January 2028.

What happened to DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE?

What happened at DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2026: profit of € 150,074 (▲ 44% vs 2025). Source: NBB ↗
Jan 1, 2010 New establishment in Merchtem. KBO
2010 Liliane Lombaert became a director. NBB
Dec 22, 2009 Start of the company according to the CBE. KBO

In short

From € 78,329 profit in 2023 to € 150,074 profit in 2026.

Paid € 141,984 in corporate taxes since 2023.

Best year ever: 2026, with € 150,074 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE? We notify you, reason included.

Follow DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Liliane Lombaert

DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE

Behind DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE is Liliane Lombaert.

See the full network in the app

Directors

According to the 2026 annual accounts

Liliane Lombaert

Director

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Spiegellaan 5

1785 Merchtem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0821.670.073
VAT number: BE 0821.670.073
Registered office: Spiegellaan 5, 1785 Merchtem
Names & denominations: DOKTER LILIANE LOMBAERT , ALGEMENE GENEESKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 December 2009
Peppol: Active · Active since 28 Apr 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗